Molecular Imaging

Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI. Molecular imaging includes the field of nuclear medicine, which uses very small amounts of radioactive materials, or radiopharmaceuticals, to diagnose and treat disease.

Trends in Cardiac Imaging Over Past Decade Show Rapid Rise in CT
October 6, 2021 – A new study published in Radiology: Cardiothoracic Imaging on cardiac imaging trends over a decade reports that the rate of coronary com
Mask Up at ASTRO21
August 11, 2021 — ASTRO announced that it is facilitating measures that seek to ensure optimal health and sanitary conditions in all environments where in-person interactions take place during the…
ASTRO 2021 Announces its October Event is In-person
July 8, 2021 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 63rd Annual Meeting, which will return to an in-person conference at …
FDA Approves Updated Aduhelm Prescribing Information
July 8, 2021 — Biogen and Eisai Co., Ltd. announced the U.S.
FDA Approves First Commercially Available PSMA PET Imaging Agent for Prostate Cancer
June 28, 2021 — The U.S. Food and Drug Administration (FDA) approved a new imaging agent for detection of prostate cancer, providing a more effective imaging approach to detect the spread of cancer to other parts of the body.

News | Computed Tomography (CT)

Philips Collaborates With Leading Institutes to Bring Its Breakthrough Spectral CT Imaging into the Interventional Suite

November 28, 2021 — Royal Philips, a leader in health technology, unveiled its vision for interventional medicine by ...

November 28, 2021

IBA, a leader in particle accelerator technology, and NorthStar Medical Radioisotopes LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced a new contract in which NorthStar will purchase a third Rhodotron TT300 HE electron beam accelerator from IBA.

News | Nuclear Imaging

IBA and NorthStar Medical Radioisotopes Sign Contract for Rhodotron Electron Beam Accelerator for Commercial Production of Therapeutic Radioisotope Actinium-225 (Ac-225)

November 22, 2021 — IBA, a leader in particle accelerator technology, and NorthStar Medical Radioisotopes LLC, a global ...

November 22, 2021

Videos | Radiopharmaceuticals and Tracers

VIDEO: Advances in Radiopharmaceutical Therapy

Ana Kiess, M.D., Ph.D., assistant professor of radiation oncology and molecular radiation sciences, Johns Hopkins ...

November 17, 2021

Sponsored Content

Staging F-18 FDG PET/CT images of adenocarcinoma in the RUL of the lung illustrates the value of Vereos. The primary lesion in the right upper lobe appears in the upper row (PET image is left, CT image is right). A 3 mm synchronous primary or metastatic lesion in the RUL is apparent in the lower row. The precision afforded by Vereos' images provided the basis for the patient to undergo RUL lobectomy instead of thermal ablation of the primary lesion. Images courtesy of Dr. Jay Kikut and UVM

Blog | PET-CT

Digital PET Balances Scan Time and Resolution

Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both. The key is the ...

October 25, 2018

18F-FDG PET in patients with long-COVID syndrome. A and B: Transaxial sections of group averaged, spatially normalized 18F-FDG PET scans in patients with long-COVID syndrome (A) and control patients (B). C: The pattern expression score (PES; *adjusted for age and sex, for illustration purposes) of the previously established COVID-19-related spatial covariance pattern was not significantly different between patients with long-COVID syndrome and control patients. Boxplots (grey), as well as individual values

News | Coronavirus (COVID-19)

Molecular Imaging Suggests Long-COVID Symptoms may be Caused by Fatigue

November 1, 2021 — Long-term cognitive problems after a COVID-19 diagnosis may be a result of fatigue rather than ...

November 01, 2021

News | Molecular Imaging

NorthStar Medical Radioisotopes Expansion Event Unveils Advanced Radioisotope Production Equipment and Breaks Ground on First-in-Kind Therapeutic Radioisotope Production Facility

October 29, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

October 29, 2021

RefleXion is developing biology-guided radiotherapy* (BgRT), which incorporates positron-emission tomography (PET) data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with sub-second latency. Currently, the RefleXion X1 machine is cleared for the delivery of stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT).

News | Radiation Oncology

RefleXion Announces Newly Formed Scientific Advisory Board

October 20, 2021 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy (BgRT) as a ...

October 20, 2021

RAD Technology Medical Systems provides complex, design-built modular facilities for the healthcare industry. #ASTRO #ASTRO21

News | Radiation Therapy

RAD Technology Medical Systems to Exhibit at the ASTRO 2021

October 19, 2021 — RAD Technology Medical Systems (RAD) announced that it will be exhibiting at the 2021 American ...

October 19, 2021

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, announced presentations on Axumin (fluciclovine F 18) and 18F-fluciclovine at the upcoming American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting

News | PET Imaging

Blue Earth Diagnostics Highlights Presentations on Axumin (Fluciclovine F 18) and 18F-Fluciclovine at ASTRO21

October 19, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

October 19, 2021

(A) CT (B) PET and (C) fused PET/CT of 68Ga-Ga-PSMA-11 PET scan of a patient with distant osseous metastases in the right proximal femur, visible on PET with intermediate PSMA uptake (SUVmax = 7.8) and missed by CT, confirmed later on follow-up CT imaging.

News | PET Imaging

PSMA PET Imaging More Accurate than CT in Detecting Hepatocellular Carcinoma

October 18, 2021 — PSMA (prostate-specific membrane antigen) PET/CT is more accurate than conventional CT in the ...

October 18, 2021

NBTXR3 is a novel, potentially first-in-class oncology product composed of functionalized hafnium oxide nanoparticles that is administered via one-time intratumoral injection and activated by radiotherapy.

News | Radiation Therapy

NANOBIOTIX to Present First Survival Data From Priority Head and Neck Cancer Program at ASTRO21

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

October 07, 2021

ViewRay, Inc. announced that the company has received acceptance from the FDA on their recent submission for new MRIdian features focused on enhancing on-table adaptive workflow efficiency and expanding clinical utility. ViewRay will be exhibiting at the annual ASTRO 2021 conference

News | Radiation Therapy

ViewRay Announces 510(k) Pending Status of the Newest Generation of MRIdian Innovations

October 7, 2021 — ViewRay, Inc. announced that the company has received acceptance from the FDA on their recent ...

October 07, 2021

Cardiac coronary computed tomography angiography (CCTA) exam showing different views of the myocardium and the coronary arteries. This was scanned on a Canon Aquilion Prime CT scanner.

Feature | Cardiac Imaging

Trends in Cardiac Imaging Over Past Decade Show Rapid Rise in CT

October 6, 2021 – A new study published in Radiology: Cardiothoracic Imaging on cardiac imaging trends over a decade ...

October 06, 2021

Images of uptake in bone metastasis in patient 2. Anterior whole-body (left) and SPECT/CT (right) images show uptake of 131I-GMIB-anti-HER2-VHH1 at level of large lytic bone metastasis, with soft-tissue component at sternal bone both at 2.5 h and at 24 h after injection. Small differences in area of uptake are explained by differences in patient positioning (arms up at 2.5 h and arms down at 24 h, to maximize patient comfort). Cts = counts. Image created by M. Keyaerts, University Hospital of Brussels (UZ B

News | Women's Health

New Radionuclide Therapy Identified for HER2-positive Breast Cancer Patients

October 5, 2021 — A promising radionuclide treatment may offer new therapeutic options for breast cancer patients ...

October 05, 2021

An illustration based on simulations by Rice University engineers shows a gadolinium ion (blue) in water (red and white), with inner-sphere water -- the water most affected by the gadolinium -- highlighted. The researchers’ models of gadolinium in water show there’s room for improvement in compounds used as contrast agents in clinical magnetic resonance imaging.

News | Magnetic Resonance Imaging (MRI)

Modern Simulations Could Improve MRIs

September 20, 2021 — Gadolinium-based contrast agents, the gold standard in magnetic resonance imaging (MRI) to ...

September 20, 2021

IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) announced a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.

News | Radiation Oncology

IBA and SCK CEN Join Forces to Enable Production of Actinium-225

September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and ...

September 17, 2021

Bicameral legislation in U.S. House and Senate designed to address equity issues in patient access and affordability for innovative diagnostic radiopharmaceuticals

News | Radiopharmaceuticals and Tracers

Blue Earth Diagnostics Supports Timely Consideration and Passage of the FIND Act of 2021 by U.S. Congress

September 17, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

September 17, 2021

Strategies to help guide nuclear radiology teams at various healthcare systems in 2021 and beyond

Feature | Nuclear Imaging | By Staff of the American Society of Nuclear Cardiology (ASNC)

5 Strategies for Improving Your Nuclear Radiology Lab

A year after COVID-19 turned the world upside down, the American Society of Nuclear Cardiology (ASNC) asked members how ...

September 16, 2021